Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
|Articles|February 25, 2022
Daily OTC Pearl: Coricidin
Coricidin is a decongestant-free treatment indicated for relief of the symptoms of a cold in patients with high blood pressure.
Advertisement
OTC/Lifestyle Pearl of the Day: Coricidin
Indication: Coricidin is a decongestant-free treatment indicated for relief of fever, runny nose, sneezing, body ache, headache, and sore throat in patients with high blood pressure.
Insight:
- Active ingredients: Acetaminophen 325 mg for pain reliever/fever reducer, chlorpheniramine maleate 2 mg as an antihistamine.
- Warning: Liver toxicity—this product contains acetaminophen. Severe liver damage may occur if you take more than 4000 mg of acetaminophen in 24 hours.
- Directions: Do not take more than the recommended dose. Take 2 tablets with water every 4-6 hours. Do not exceed 10 tablets in 24 hours or as directed by a physician.
- Children under 12 years of age should not use.
- Storage: Store between 20º to 25ºC (68º to 77ºF)
Sources:
Advertisement
Related to this article
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What the 2025-2030 Dietary Guidelines Mean for Heart Health
2
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
3
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
4
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL
5